Bora Pharmaceuticals Secures US FDA Approval for Restasis® Generic; USL to Lead Launch

Bora Pharmaceuticals (保瑞) announced on the 22nd that its subsidiary, Upsher-Smith Laboratories (USL), has received US FDA approval for its Abbreviated New Drug Application (ANDA) for Cyclosporine Ophthalmic Emulsion 0.05%, a generic version of AbbVie/Allergan’s Restasis®.